-+ 0.00%
-+ 0.00%
-+ 0.00%

Rallybio Announces Annual Stockholder Meeting

PUBT·10/26/2026 20:54:42
Listen to the news
Rallybio Announces Annual Stockholder Meeting
  • Rallybio will hold its annual shareholder meeting on November 4, 2026, to vote on its merger with Avenzo Therapeutics.
  • Shareholder approval is required for a special cash distribution estimated at $82.7 million, or $13.56 per share.
  • The merger is expected to close around November 6, 2026, subject to shareholder approval and other closing conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-432114), on October 26, 2026, and is solely responsible for the information contained therein.